|Articles|June 16, 2022
Yseop’s AI Natural Language Platform Scaled by Sanofi to Accelerate Medical Writing and Reporting Processes
After four successful years of collaborating, Sanofi plans to expand Yseop’s platform for pharma and vaccine use cases.
Advertisement
Yseop announced that Sanofi has chosen to scale its natural language generation (NLG) capabilities with Yseop. Sanofi will use the platform to accelerate its clinical study submission processes and bring new treatments to patients faster.
Read more about platform
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Drug Repurposing Through AI-Driven In-Silico Clinical Trials
2
2025 Veeva R&D and Quality Summit: Effectively Utilizing Clinical Reference Data
3
New ICON Survey Shows Sites Face Growing Delays and Communication Gaps During Study Startup
4
Former FDA Commissioners Warn New Vaccine Policies Could Undermine Longstanding Regulatory Framework
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
